The Deal
Sunday, November 8, 
3:48 pm

M&A: How to avoid 'gun jumping'

[ Share ]  [ E-mail ]  [ Leave a Comment ]
RunnerPenalizedFalseStartTrack.pngMcDermott Will & Emery LLP put together a newsletter entitled Inside M&A. Their first subject: Improper premerger coordination, or "gun jumping." Washington partners Jon Dubrow and Stefan Meisner explain how to reduce the risk of being accused of the practice, which is barred by both the Hart-Scott-Rodino Act and Section 1 of the Sherman Act.

They say merging parties should consult with counsel early in the process to establish antitrust guidelines that govern all integration planning and related preclosing activities. The Deal's Bill McConnell writes that the gun-jumping ban is intended to keep the companies as fully separate competitors while an antitrust review is underway. He cites Qualcomm Inc. as an example of what not to do; the Department of Justice dinged Qualcomm for nearly $2 million for jumping the gun on its acquisition of Flarion Technologies Inc.

McDermott's newsletter offers some key principles:

  1. Avoid improper information exchange during due diligence and transition planning.
  2. Minimize coordination on significant preclosing projects or contracts.
  3. All preclosing conduct covenants in any merger or acquisition agreement must be reviewed to ensure that they comply with applicable antitrust rules.
  4. Merging parties should seek, whenever possible, to minimize the time that elapses between execution of a merger agreement and the closing of the transaction.
  5. Joint marketing of the transaction is permissible accompanied by strict guidelines that ensure independent ongoing competition until the transaction closes.
The newsletter also contains articles on special purpose acquisition companies, or SPACs, and the German Securities Trading Act Notice requirements following M&A transactions. - Baz Hiralal

Join Corporate Dealmaker's LinkedIn forum

Comments
Post a comment


Search


Search For

Corporate Dealmaker Video


Linklaters' Schmidt on Pfizer-Wyeth review

Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.
Decade of The Deal


Movers & Shakers


Juergen Lasowski
Onyx Pharmaceuticals Inc.

Edward Swallow
Northrop Grumman Corp.

Owen Mahoney
Outspark

Alice Kim
FLO TV Inc.

Eric Hausler
Isle of Capri Casinos Inc.
Juergen Lasowski, Onyx Pharmaceuticals Inc.
Edward Swallow, Northrop Grumman Corp.
Owen Mahoney, Outspark
Alice Kim, FLO TV Inc.
Eric Hausler, Isle of Capri Casinos Inc.


COMPLETE MOVERS & SHAKERS ARCHIVES

The Magazine


MACDdec1cover.gifAnd the winners are...
Even in a period when things like toxic credit default swaps and noxious structured investment vehicles dominate the conversation in many parts of the deal community, people are still willing to take the time to recognize skill and achievement in the strategic transactions that help those companies adapt and grow.
View the complete issue


Last Issue
Archives
Suggest a topic
Purchase a reprint
Subscribe to The Deal


Monthly Archives


Syndicate

Contributors

footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.